In conclusion, our study provides evidence that irisin induced by exercise prevents inflammation in NAFLD by competitively binding with MD2 and highlights a new role of irisin as an antagonist of the TLR4 pathway, where the only known irisin receptor to date is the αV integrin receptor [23]. Here, LY96 is linked to metabolic dysfunction-associated steatotic liver disease.